Washington — Federal officials say the pause in use of the Johnson & Johnson Covid-19 vaccine will last just days.
The federal Food and Drug Administration and Centers for Disease Control and Prevention called for a temporary stop to use of the vaccine in the U.S. after reports that a small number of recipients developed a rare disorder involving blood clots. Federal vaccination sites are pausing use of the shot and multiple states, including New York, are following suit.
But the pause is likely to last “a matter of days,” not weeks or months, Dr. Janet Woodcock, acting FDA commissioner, said today, according to The Associated Press.
Agencies plan to investigate the clotting disorder. Regulators also want to educate patients and medical professionals about spotting and treating the clots, AP said.
People who have received the Johnson & Johnson vaccine and get a severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their doctor, according to the FDA and CDC.
White House officials said this morning that they do not expect the Johnson & Johnson pause to have a major effect on the nation’s plan to administer 200 million Covid shots by the end of April, according to CNN.
“Johnson & Johnson vaccine makes up less than 5 percent of the recorded shots in arms in the United States to date,” White House Covid coordinator Jeff Zients said in a statement, according to the network. “Based on actions taken by the president earlier this year, the United States has secured enough Pfizer and Moderna doses for 300 million Americans. Over the last few weeks, we have made available more than 25 million doses of Pfizer and Moderna each week, and in fact this week we will make available 28 million doses of these vaccines.”
The Pfizer and Moderna shots each require two doses. The J&J shot requires just one and is easier to ship and store.
Anyone with a J&J appointment scheduled for today at a vaccine site run by New York state can still go, including people with appointments at the New York State Fairgrounds. Individuals will receive the Pfizer vaccine instead.
Onondaga County officials also announced they will stop using the Johnson & Johnson shot. Anyone already scheduled to get that vaccine from the county will be switched to Pfizer or Moderna.
The six people who developed the clotting condition represent a tiny fraction of the nearly 7 million people who have received the Johnson & Johnson shot in the U.S. so far. Officials said they were recommending a pause in use of the vaccine “out of an abundance of caution.”
The recipients who developed the disorder were all women between the ages of 18 and 48, the Times said. One woman died and another in Nebraska has been hospitalized in critical condition.
The Pfizer and Moderna vaccines have both been in use in the U.S for months and tens of millions of people have received them. No safety issues involving the shots have emerged.
Johnson & Johnson did say it will delay the rollout of its vaccine in Europe in the wake of the clotting reports, according to The New York Times.
MORE ON CORONAVIRUS
Coronavirus in NY: Cases, maps, charts and resources
NYS Fairgrounds cancels Johnson & Johnson vaccine distribution, will give out Pfizer instead
Syracuse Mets will require Covid-19 tests, vax info from fans, a new sign of summer
Cuomo details new rules for graduation ceremonies at New York schools, colleges
Complete coronavirus coverage on syracuse.com
Contact Kevin Tampone anytime: Email | Twitter | Facebook | 315-282-8598
"last" - Google News
April 13, 2021 at 11:04PM
https://ift.tt/2QpL2XR
Johnson & Johnson vaccine pause to last ‘matter of days,’ officials say - syracuse.com
"last" - Google News
https://ift.tt/2rbmsh7
https://ift.tt/2Wq6qvt
Bagikan Berita Ini
0 Response to "Johnson & Johnson vaccine pause to last ‘matter of days,’ officials say - syracuse.com"
Post a Comment